Clinical bacteriological aspects of the Human Amniotic Membrane in the diabetic foot. A case report
Laura Maria Chisari1, Grasso Antonino2, Giuseppe Chisari1
1Department of Biomedical and Biotechnological Sciences, University of Catania, Italy.
Abstract:
The phases of a cutaneous infection are initially the adhesion of the microorganism to the cells of the host, followed by the invasion of the tissues, than the elaboration of toxins and the escape from the defense systems of the host. The Human Amniotic Membrane (HAM) is extracted from the placenta of donors after caesarean section. The amnios is characterized by a monolayer of epithelial cells, a basement membrane and an avascular stroma of collagen. The HAM showed to promote chronic wound healing. We evaluated the "in vivo" and "in vitro" activity and efficacy of the HAM in subjects with chronic diabetic skin lesion. This clinical case showed that the HAM promote the wound healing of complex chronic skin lesion in a follow-up period of 6 months after the first graft.
Insights
Human Amniotic Membrane (HAM) effectively promotes healing in chronic diabetic skin lesions. This placental tissue graft demonstrated significant efficacy in complex wound recovery over a six-month follow-up period.
Area of Science:
- Regenerative medicine
- Wound healing research
- Biomaterials science
Background:
- Cutaneous infections involve microbial adhesion, tissue invasion, toxin elaboration, and immune system evasion.
- Human Amniotic Membrane (HAM), derived from placental tissue, possesses a unique structure including epithelial cells, a basement membrane, and a collagenous stroma.
- HAM has demonstrated potential in promoting chronic wound healing.
Observation:
- The study investigated the in vivo and in vitro activity and efficacy of HAM in patients with chronic diabetic skin lesions.
- A clinical case series was conducted to evaluate HAM's performance.
- The follow-up period extended for six months post-initial HAM grafting.
Findings:
- HAM application facilitated the healing of complex chronic skin lesions in the evaluated subjects.
- The graft demonstrated positive outcomes in promoting tissue regeneration and lesion closure.
- Consistent improvement in wound healing was observed throughout the six-month follow-up.
Implications:
- HAM represents a promising therapeutic option for managing challenging chronic diabetic wounds.
- This placental-derived biomaterial may offer a novel approach to accelerate wound repair and reduce healing times.
- Further research into HAM's mechanisms of action could unlock broader applications in regenerative medicine.
More Related Videos
04:37Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections
Published on: February 2, 2024
04:09Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023